Peroxisome proliferator-activated receptor delta-PPARδ agonist (L-165041) enhances bovine embryo survival and post vitrification viability.

The effect of L-165041 (PPARδ-agonist) on decreasing apoptosis and intracellular lipid content was assessed in fresh and vitrified-warmed in vitro -produced bovine embryos. It was hypothesised that the addition of L-165041 to the culture medium enhances development and cryopreservation. Oocytes were allocated to one of two treatments: control-standard culture medium, or L-165041 added to the medium on day1 with no media change. Ultrastructure, cleavage, and blastocyst rates were evaluated in fresh, and in post-vitrification cultured embryos by optical and electronic microscopy. A subset of fresh embryos were fixed for TUNEL assay and for Sudan-Black-B histochemical staining. Vitrified-warmed embryos were assessed using MALDI-MS technique. Cleavage and blastocyst rates (control 49.4±5.2, L-165041 51.8±4.3) were not influenced by L-165041. The proportion of inner cell mass cells (ICM) was higher in fresh embryos, and the rate of total and ICM apoptosis was lower in L-165041. In warmed-embryos, total and ICM apoptosis was lower in L-165041. The overall hatching rate was higher in L-165041 (66.62±2.83% vs 53.19±2.90%). There was less lipid accumulation in fresh L-165041-embryos. In conclusion, the use of L-165041 is recommended to improve the viability of in vitro -derived bovine embryos.

Ultrasonographic cervical evaluation: A tool to select ewes for non-surgical embryo recovery.

This study assessed the cervical ultrasonography mapping as a tool to select donor ewes for non-surgical embryo recovery (NSER). Lacaune ewes had their cervix evaluated by ultrasonography 12 hr after induced oestrus onset (Trial 1, n = 24) or 30 min before NSER (Trial 2, n = 17). Cervical rings were longitudinally evaluated and classified by their degree of misalignment on ultrasonography (DMUS) into: DMUS-1-cervix rectilinear, DMUS-2-intermediate and DMUS-3-highly asymmetrical. For predicting cervical transposing, only DMUS-1 and DMUS-2 were considered suitable. Similar ranking was attributed to degree of misalignment on the cervical map (DMCM 1-3), established immediately before NSER, which was performed at days 6 to 7 after oestrus. In Trial 1, cervical retraction for NSER was not possible only in three ewes classified as DMUS-3 (3/14, 21.4%). No difference (p > .05) was observed in the cervical transposing rates between ewes with different DMUS (ranged from 80% to 100%). In Trial 2, DMUS-1 and DMUS-2 reached 100% of transposing, and the only DMUS-3 ewe has not been transposed. In Trial 1, the prediction performance for successful cervical transposing showed low sensitivity (45%) and no specificity due to a high incidence of false negatives (52%). However, in Trial 2, sensitivity and specificity were both 100%. The DMCM and DMUS were uncorrelated, probably due to cervical stretching required to perform NSER. In conclusion, cervical ultrasound assessment immediately before NSER was more efficient to predict the cervical transposing than at induced oestrus, allowing the classification and selection of ewes eligible for NSER.

Bayesian factor analytic model: An approach in multiple environment trials.

One of the main challenges in plant breeding programs is the efficient quantification of the genotype-by-environment interaction (GEI). The presence of significant GEI may create difficulties for breeders in the selection and recommendation of superior genotypes for a wide environmental network. Among the diverse statistical procedures developed for this purpose, we highlight those based on mixed models and factor analysis that are called factor analytic (FA) models. However, some inferential issues are related to the factor analytic model, such as Heywood cases that make the model non-identifiable. Moreover, the representation of the loads and factors in the conventional biplot does not involve any measurement of uncertainty. In this work, we propose dealing with the FA model using the Bayesian framework with direct sampling of factor loadings via spectral decomposition; this guarantees identifiability in the estimation process and eliminates the need for the rotationality of factor loadings or imposition of any ad hoc constraints. We used simulated and real data to illustrate the method's application in multi-environment trials (MET) and to compare it with traditional FA mixed models on controlled unbalancing. In general, the Bayesian FA model was robust under different simulated unbalanced levels, presenting the superior predictive ability of missing data when compared to competing models, such as those based on FA mixed models. In addition, for some scenarios, the classical FA mixed model failed in estimating the full FA model, illustrating the parametric problems of convergence in these models. Our results suggest that Bayesian factorial models might be successfully used in plant breeding for MET analysis.

Can Resveratrol Treatment Control the Progression of Induced Periodontal Disease? A Systematic Review and Meta-Analysis of Preclinical Studies.

Resveratrol is an anti-inflammatory compound found in several foods. Periodontal disease (PD) is associated to other systemic diseases, and inflammation may be responsible for the association. Consequently, controlling inflammation not only may benefit oral health but also may assist with the management of other chronic inflammatory conditions. We aimed to investigate the effects of resveratrol administration on PD control in preclinical studies. A systematic search was performed for scientific articles using both electronic databases and a manual search using combinations of the following keywords: "resveratrol" OR "3,5,4'-trihydroxystilbene" AND "periodontal disease" OR "periodontitis" OR "gingivitis". Only in vivo original studies investigating resveratrol treatment on experimental animal models of PD were selected. A quality assessment of the studies was performed using the Animal Research Reporting In Vivo Experiment (ARRIVE) guidelines, and the risk of bias was assessed using the Syrcle tool. The search returned 570 articles, and 11 matched the inclusion criteria. A meta-analysis showed that resveratrol treatment attenuated alveolar bone loss (τ2 = 0.0041; 95% CI: -0.14; -0.04). The ARRIVE criteria reported a good quality of studies in general (mean score 28.5 ± 2.5). However, five Syrcle domains indicated a high risk of bias or did not present information clearly. We concluded that, in preclinical studies, resveratrol treatment prevented PD progression.

Níveis da bacitracina de zinco como melhorador do desempenho de frangos de corte / Levels of zinc bacitracin used to improve the performance of broilers

A utilização de antimicrobianos melhoradores de desempenho na criação de frangos de corte é uma prática comum na indústria avícola e, no Brasil, seu uso deve ser feito de acordo com os limites determinados pelo Ministério da Agricultura Pecuária e Abastecimento (MAPA).Objetivou-se com o presente trabalho determinar o efeito da utilização da bacitracina de zinco, dentro dos níveis recomendados pelo Ministério da Agricultura Pecuária e Abastecimento (MAPA), em dietas para frangos de corte sobre o desempenho de aves e criadas de 1 a 42 dias de idade. Utilizou-se o delineamento inteiramente casualizado, com 5 tratamentos, distribuídos em 10 repetições de 25 pintos machos de corte da linhagem Cobb 500®, totalizando 1250 aves. Os tratamentos experimentais foram constituídos de cinco níveis de inclusão de bacitracina de zinco (0, 10, 25, 40 e 55ppm). As variáveis analisadas foram consumo de ração, ganho de peso, conversão alimentar e avaliação econômica das dietas. Para o período total de criação, avaliou-se também a viabilidade dos frangos de corte. A bacitracina de zinco foi eficiente como beneficiador do desempenho de frangos de corte criados no período de 1 a 21, 1 a 35 e 1 a 42 dias. Para o período de 1 a 21 dias, o uso de 55 e 29,3ppm de bacitracina de zinco resultou em menor consumo de ração e maior ganho de peso, respectivamente. No geral, a melhor conversão alimentar foi obtida quando se adicionou 55ppm de bacitracina de zinco na ração de frangos de corte.

The use of growth promoters in the broilers production is a common practice in the poultry industry and its use must be made accordance with limits in Brazil set by the Ministry of Agriculture, Livestock and Supply (MAPA).The main objective of this study was to verify the effect of the use of zinc bacitracin, within the levels recommended by the Brazilian Ministry of Agriculture, Livestock and Food Supply (MAPA), in broiler diets for the performance of birds from 1 to 42 days old. We used a randomized design with five treatments in 10 replications of 25 male chicks from Cobb cut 500®, totaling 1250 birds. The treatments consisted of five inclusion levels of zinc bacitracin (0, 10, 25, 40 and 55ppm). The variables studied were feed intake, weight gain, feed conversion and economic evaluation of feed. For the breeding period as a whole, this study also evaluated the viability of broilers. Zinc bacitracin was effective as growth promoter of broilers reared during 1 to 21, 1 to 35 and 1 to 42 days. For the period 1-21 days, using 55 and 29.3ppm of zinc bacitracin resulted in a lower feed intake and increased weight gain, respectively. In general, the best feed conversion was obtained when 55ppm of zinc bacitracin was added to the feed of broilers.